Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/175298
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCruz Martínez, Ofelia-
dc.contributor.authorCaloretti, Victoria-
dc.contributor.authorSalvador, Héctor-
dc.contributor.authorCelis, Verónica-
dc.contributor.authorSanta-Maria Lopez, Vicente-
dc.contributor.authorMorales La Madrid, Andrés-
dc.contributor.authorSuñol, Mariona-
dc.contributor.authorPuerta, Patricia-
dc.contributor.authorMuchart López, Jordi-
dc.contributor.authorKrauel, Lucas-
dc.contributor.authorLavarino, Cinzia-
dc.date.accessioned2021-03-18T11:06:37Z-
dc.date.available2021-03-18T11:06:37Z-
dc.date.issued2021-01-06-
dc.identifier.issn1731-2302-
dc.identifier.urihttp://hdl.handle.net/2445/175298-
dc.description.abstractBackground: Li-Fraumeni Syndrome (LFS) is a cancer predisposition syndrome characterized by the early-onset of multiple primary cancers which can occur at different moments (metachronous onset) or, more rarely, coincidentally (synchronous onset). Here we describe a previously unreported patient with presentation of synchronous Wilms tumor and Choroid plexus papilloma, leading to the diagnosis of a Li-Fraumeni Syndrome (LFS). Case presentation: A 6-year-old girl without previous complains presented with abdominal pain. Abdominal US and MRI showed a left renal tumor with subcapsular hematoma. Due to mild headaches, the diagnostic workup included a brain MRI that unexpectedly identified a large left parietal lobe tumor. Histopathological analysis determined the diagnosis of classic Wilms tumor and choroid-plexus papilloma (CPP), respectively. Both neoplasms showed intense nuclear p53 immunostaining associated with the pathogenic TP53 mutation c.844C > T (p.Arg282Trp). Our patient and her father shared the same heterozygous germline TP53 mutation, confirming the diagnosis of familiar Li-Fraumeni syndrome in the girl. The treatment was tailored to simultaneous tumor presentations. Conclusions: LFS has been associated with Choroid plexus carcinoma (CPC), but rarely with CPP as in our patient. That suggests that it may be advisable to consider the possibility of analyzing TP53 mutation, not only in all patients with CPC, but also in some patients with CPP, especially when histological or clinical evidences point out to perform this study. The dissimilar presentation of LFS among our patient's father, not having so far any neoplasia diagnosed, while her daughter presented precociously with two simultaneous different tumors, could be related to possible effects of modifier genes on the underlying mutant p53 genotype.-
dc.format.extent6 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13053-020-00158-7-
dc.relation.ispartofHereditary Cancer in Clinical Practice , 2021, vol. 19, num. 1-
dc.relation.urihttps://doi.org/10.1186/s13053-020-00158-7-
dc.rightscc-by (c) Cruz Martínez, Ofelia et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)-
dc.subject.classificationTumors-
dc.subject.classificationPapil·lomavirus-
dc.subject.classificationHistopatologia-
dc.subject.otherTumors-
dc.subject.otherPapillomaviruses-
dc.subject.otherPathological histology-
dc.titleSynchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec706106-
dc.date.updated2021-03-18T11:06:37Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid33407742-
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
706106.pdf2.45 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons